DocDollars

Teikoku Pharma USA, Inc.

CA · United States · Reporting entity ID 100000276807

Total reported 2019–2025
$19.1M
#332 of 2,960 reporting companies — 0% of all reported industry payments
$222K in general payments across 17 records, plus $18.9M in research funding across 5 records.

How it breaks down

General payments $221,587
Research funding $18,901,707

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Teikoku Pharma USA, Inc. reported $19.1M to US doctors and teaching hospitals from 2019 to 2025, ranking #332 of 2,960 reporting companies. 99% of that was research funding and 1% general payments such as consulting, speaking, food and travel. 17 general payment records and 5 research records were filed.

Common questions about Teikoku Pharma USA, Inc.

How much has Teikoku Pharma USA, Inc. paid US doctors?

Teikoku Pharma USA, Inc. reported $19,123,293 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $221,587 in general payments, $18,901,707 in research funding.

How does Teikoku Pharma USA, Inc. rank among drug and device companies?

It ranks #332 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Teikoku Pharma USA, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.